Amneal Pharmaceuticals In... (AMRX)
8.03
0.18 (2.29%)
At close: Jan 15, 2025, 12:41 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Net Income | -48.72M | -254.79M | 20.17M | 68.58M | -603.57M | -201.30M | 169.32M | 209.43M | 169.45M | 176.93M |
| Depreciation & Amortization | 229.40M | 240.18M | 233.41M | 235.39M | 207.24M | 137.40M | 45.94M | 33.02M | 25.45M | 20.34M |
| Stock-Based Compensation | 26.82M | 31.85M | 28.41M | 20.75M | 21.68M | 167.60M | n/a | n/a | n/a | n/a |
| Other Working Capital | 47.15M | 12.60M | -17.02M | 35.37M | 43.16M | 16.01M | -22.58M | 6.65M | n/a | n/a |
| Other Non-Cash Items | 185.26M | 107.81M | 10.04M | 19.96M | 124.86M | 148.96M | 14.52M | 3.25M | -90.02M | -85.01M |
| Deferred Income Tax | n/a | n/a | 83.39M | 95.64M | 371.72M | -9.44M | 742.00K | 121.00K | n/a | n/a |
| Change in Working Capital | -47.19M | -59.95M | -133.59M | -61.32M | -120.22M | 7.01M | -1.05M | -152.15M | -122.73M | -93.28M |
| Operating Cash Flow | 345.58M | 65.10M | 241.82M | 379.00M | 1.71M | 250.23M | 234.19M | 115.06M | 104.88M | 112.26M |
| Capital Expenditures | -69.19M | -90.59M | -52.64M | -66.19M | -97.43M | -97.09M | -114.27M | -124.61M | -117.38M | -79.38M |
| Acquisitions | n/a | -84.71M | -146.54M | -251.36M | 34.83M | -324.63M | 15.72M | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -22.39M | 1.00M | 5.00M | -255.71M | 43.02M | 25.34M | -3.78M | -1.85M | -18.24M | -41.60M |
| Investing Cash Flow | -69.19M | -174.31M | -194.18M | -317.55M | -19.58M | -396.38M | -98.55M | -124.61M | -135.62M | -120.98M |
| Debt Repayment | -196.35M | -123.27M | -78.18M | 142.99M | -29.27M | 541.05M | 286.10M | 188.60M | 186.99M | 298.50M |
| Common Stock Repurchased | -2.38M | -3.57M | -2.66M | -863.00K | -926.00K | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | -183.00M | -375.26M | -200.62M | -258.17M | -243.00M |
| Other Financial Acitivies | -13.85M | 20.22M | -57.28M | -11.18M | -16.56M | -70.37M | -5.85M | -7.48M | 46.19M | -7.43M |
| Financial Cash Flow | -212.57M | -106.62M | -138.12M | 131.81M | -45.83M | 287.68M | -95.02M | -19.50M | -24.99M | 48.07M |
| Net Cash Flow | 63.88M | -221.51M | -90.38M | 194.30M | -65.96M | 140.86M | 40.38M | -27.56M | -56.44M | 35.64M |
| Free Cash Flow | 276.39M | -25.50M | 189.18M | 312.81M | -95.73M | 153.14M | 119.92M | -9.55M | -12.50M | 32.87M |